Last gasp pro-generics shift from government enrages Italian pharma
This article was originally published in Scrip
Executive Summary
A "drastic measure" that "hits at the heart of the pharmaceutical industry in Italy" has been sneaked through in an eleventh-hour late-night amendment to the comprehensive Spending Review legislation, Farmindustria, the industry association, has warned. Assogenerici, the Italian association of generic pharmaceutical companies, on the other hand, has applauded the provision, saying it could enable major savings in public health spending.